Top Story

Ivosidenib induces durable responses in relapsed, refractory acute myeloid leukemia

July 16, 2018

Leukemia & Lymphoma Society appoints board members, names chief operating officer

July 14, 2018
The Leukemia & Lymphoma Society appointed five new members to its board of directors and also named its new chief operating officer.
In the Journals Plus

American Cancer Society creates blueprint to reduce cancer mortality by 2035

July 10, 2018
Researchers from the American Cancer Society identified trends in disparities and outcomes for cancer over the last few decades in an effort to highlight the need for…

Fratricide-resistant CAR T-cell therapy may have utility in acute lymphoblastic leukemia

July 5, 2018
Patients with relapsed or refractory acute lymphoblastic leukemia may benefit from a novel fratricide-resistant chimeric antigen receptor T-cell therapy approach…
More Headlines »

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
ASCO Annual Meeting

ASCO Annual Meeting


Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

There is no commercial support for this activity.

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman…
More »